Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Teclison Ltd.
Teclison Ltd.
Turning Point Therapeutics, Inc.
Crinetics Pharmaceuticals Inc.
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Chimeric Therapeutics
Tanabe Pharma America, Inc.
Perspective Therapeutics
BioXcel Therapeutics Inc
Hutchmed
PharmaMar
Hoffmann-La Roche
Hutchmed
23andMe, Inc.
Ipsen
Tarveda Therapeutics
Ipsen
Arbutus Biopharma Corporation
Molecular Insight Pharmaceuticals, Inc.